Previous Article | Next Article ![]()
Mol. Cell. Biol., 06 1996, 2814-2822, Vol 16, No. 6
N Jarrous, F Osman and R Kaempfer
2-Aminopurine (2-AP) inhibits specific kinases that phosphorylate the alpha
subunit of eukaryotic translation initiation factor 2. One of these, PKR,
is also involved in signal transduction. We show here that 2-AP selectively
inhibits expression of tumor necrosis factor alpha (TNF-alpha) mRNA in
primary human lymphoid cells. 2-AP does not inhibit transcription of the
human TNF-alpha gene, nor does it affect mRNA stability. Instead, the flow
of short-lived precursor transcripts into mature TNF-alpha mRNA is blocked.
When 2-AP is present during induction, unspliced TNF-alpha precursor
transcripts accumulate at the expense of mRNA. Using RNase protection
analysis with genomic probes for different exon-intron junctions, we show
that 2-AP blocks splicing of TNF-alpha mRNA. Neither the TNF-beta nor the
interleukin-1 beta gene shows such regulation. 2-AP also inhibits splicing
of precursor RNA transcribed from an exogenous human TNF-alpha gene.
Sequences within this gene thus confer sensitivity to 2-AP. Yet, control is
not exerted at a specific splice site. Our results reveal the involvement
of a 2-AP- sensitive component, expressed in functional form before
induction, in the splicing of TNF-alpha mRNA.
Copyright © 1996, American Society for Microbiology
2-Aminopurine selectively inhibits splicing of tumor necrosis factor alpha mRNA
Department of Molecular Virology, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»